Filing Details
- Accession Number:
- 0000921895-17-001998
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-28 17:16:17
- Reporting Period:
- 2017-07-27
- Filing Date:
- 2017-07-28
- Accepted Time:
- 2017-07-28 17:16:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 811641 | Immucell Corp | ICCC | In Vitro & In Vivo Diagnostic Substances (2835) | 010382980 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1582758 | L. Brian Pessin | 310 East 75Th Street Apt. 2A New York NY 10021 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-27 | 30,000 | $5.25 | 70,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock.
Billionaire Hedge Funds
